ENTRY       D11686                      Drug
NAME        Plamotamab (USAN/INN)
FORMULA     C5571H8576N1490O1722S37
EXACT_MASS  125085.8973
MOL_WEIGHT  125163.0579
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYNMHWVRQA PGQGLEWMGA IYPGNGDTSY
            NQKFQGRVTI TADKSISTAY MELSSLRSED TAVYYCARST YYGGDWYFNV WGAGTLVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SDTKVDKKVE PKSCDKTHTC PPCPAPPVAG
            PSVFLFPPKP KDTLMISRTP EVTCVVVDVK HEDPEVKFNW YVDGVEVHNA KTKPREEEYN
            STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE
            MTKNQVSLTC DVSGFYPSDI AVEWESDGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW
            EQGDVFSCSV MHEALHNHYT QKSLSLSPGK
            (Light chain)
            QIVLTQSPSS LSASVGDRVT ITCRASSSVS YIHWFQQKPG KSPKPLIYAT SNLASGVPVR
            FSGSGSGTDY TLTISSLQPE DFATYYCQQW TSNPPTFGGG TKVEIKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (heavy chain)
            EVQLVESGGG LVQPGGSLRL SCAASGFTFS TYAMNWVRQA PGKGLEWVGR IRSKYNNYAT
            YYADSVKGRF TISRDDSKNT LYLQMNSLRA EDTAVYYCVR HGNFGDSYVS WFAYWGQGTL
            VTVSSGKPGS GKPGSGKPGS GKPGSQAVVT QEPSLTVSPG GTVTLTCGSS TGAVTTSNYA
            NWVQQKPGKS PRGLIGGTNK RAPGVPARFS GSLLGGKAAL TISGAQPEDE ADYYCALWYS
            NHWVFGGGTK LTVLEPKSSD KTHTCPPCPA PPVAGPSVFL FPPKPKDTLM ISRTPEVTCV
            VVDVKHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV VSVLTVLHQD WLNGKEYKCK
            VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREQMTKNQ VKLTCLVKGF YPSDIAVEWE
            SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV FSCSVMHEAL HNHYTQKSLS
            LSPGK
            (Disulfide bridge: H22-H96, H148-H204, H224-L213, H230-h265, H233-h268, H264-H324, H370-H428, L23-L87, L133-L193, h22-h98, h167-h235, h299-h359, h405-h463)
  TYPE      Peptide
EFFICACY    Antineoplastic, Immunomodulator, Anti-CD20 antibody, Anti-CD3 antibody
  TYPE      Monoclonal antibody, bispecific antibody
TARGET      CD20 [HSA:931] [KO:K06466]
            CD3E [HSA:916] [KO:K06451]
  PATHWAY   hsa04640(916+931)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD3E
                 D11686  Plamotamab (USAN/INN)
                CD20
                 D11686  Plamotamab (USAN/INN)
DBLINKS     CAS: 2138442-31-4
            PubChem: 405226552
///
